Stoxx Europe 50

Stoxx Europe 50 handeln
5.125,52 PKT +43,20 PKT +0,85 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 965816

ISIN EU0009658160


Analysen zu Stoxx Europe 50-Werten

Datum Rating Analyst
29.10.25 GSK Outperform Bernstein Research
29.10.25 Air Liquide Buy Deutsche Bank AG
29.10.25 Novartis Neutral UBS AG
29.10.25 Santander Buy Jefferies & Company Inc.
29.10.25 Iberdrola SA Buy UBS AG
29.10.25 Santander Buy UBS AG
29.10.25 SAP Buy UBS AG
29.10.25 GSK Neutral UBS AG
29.10.25 GSK Buy Jefferies & Company Inc.
29.10.25 BNP Paribas Halten DZ BANK
29.10.25 GSK Underweight JP Morgan Chase & Co.
29.10.25 Air Liquide Outperform Bernstein Research
29.10.25 UBS Outperform RBC Capital Markets
29.10.25 UBS Buy Jefferies & Company Inc.
29.10.25 UBS Overweight JP Morgan Chase & Co.
29.10.25 Santander Sector Perform RBC Capital Markets
29.10.25 HSBC Overweight Barclays Capital
29.10.25 Novartis Hold Jefferies & Company Inc.
29.10.25 Air Liquide Neutral JP Morgan Chase & Co.
28.10.25 BNP Paribas Outperform RBC Capital Markets
28.10.25 Iberdrola SA Verkaufen DZ BANK
28.10.25 LOréal Underperform Jefferies & Company Inc.
28.10.25 TotalEnergies Outperform RBC Capital Markets
28.10.25 Shell (ex Royal Dutch Shell) Outperform RBC Capital Markets
28.10.25 Novartis Hold Jefferies & Company Inc.
28.10.25 Iberdrola SA Buy UBS AG
28.10.25 BNP Paribas Neutral UBS AG
28.10.25 HSBC Neutral UBS AG
28.10.25 Air Liquide Buy UBS AG
28.10.25 Iberdrola SA Buy Jefferies & Company Inc.
28.10.25 BNP Paribas Buy Jefferies & Company Inc.
28.10.25 UniCredit Buy Goldman Sachs Group Inc.
28.10.25 Sanofi Neutral Goldman Sachs Group Inc.
28.10.25 HSBC Sector Perform RBC Capital Markets
28.10.25 Iberdrola SA Sector Perform RBC Capital Markets
28.10.25 BNP Paribas Outperform RBC Capital Markets
28.10.25 Air Liquide Buy Jefferies & Company Inc.
28.10.25 Air Liquide Neutral JP Morgan Chase & Co.
28.10.25 Iberdrola SA Neutral JP Morgan Chase & Co.
28.10.25 Novartis Neutral JP Morgan Chase & Co.